Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© ). - Taher A; Cappellini MD; Viprakasit V; Sutcharitchan P; Mahmoud D; Laadem A; Khan A; Gwaltney C; Harding G; Attie K; Zhang X; Zou J; et al. (American journal of hematology, 2019)